Welcome to LookChem.com Sign In|Join Free

CAS

  • or

60-92-4

Post Buying Request

60-92-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • Cyclic AMP CAS 60-92-4 3'-5' Cyclic adenosine monophosphate CAS no 60-92-4 Adenosine 3′,5′-cyclic monophosphate

    Cas No: 60-92-4

  • USD $ 3.5-5.0 / Kiloliter

  • 5 Kiloliter

  • 3000 Metric Ton/Month

  • Chemwill Asia Co., Ltd.
  • Contact Supplier

60-92-4 Usage

Chemical Properties

White crystalline or Pale yellow powder; odorless. Slightly soluble in water, almost insoluble in ethanol or ether.

Uses

cAMP is used for intracellular signal transduction in many different organisms, conveying the cAMP-dependent pathway. Restoration of several morphological characteristics of normal fibroblasts in sarcoma cells when treated with adenosine-3': 5'-cyclic monophosphate. In the presence of adenosine 3':5'-cyclic monophosphate, protein kinase I dissociated into two subunits: a subunit binding adenosine 3':5'-cyclic monophosphate, and a catalytic subunit. Stimulation of calcium uptake in platelet membrane vesicles by adenosine 3',5'-cyclic monophosphate.

Definition

ChEBI: Cyclic AMP is a 3',5'-cyclic purine nucleotide having having adenine as the nucleobase. It has a role as a human metabolite, an Escherichia coli metabolite and a mouse metabolite. It is an adenyl ribonucleotide and a 3',5'-cyclic purine nucleotide. It is a conjugate acid of a 3',5'-cyclic AMP(1-).

General Description

Cyclic AMP is a second messenger molecule comprised of an adenine ribonucleotide bearing a phosphate group bound to the oxygen molecules at the 3' and 5' positions of the sugar moiety. Cyclic AMP, which is synthesized from ATP by the intracellular enzyme adenylate cyclase, modulates the activity of several hormone-dependent signal transduction pathways.

Safety Profile

Human mutation data reported.When heated to decomposition it emits toxic fumes ofPOx and NOx.

Synthesis

Cyclic AMP is synthesized from ATP by adenylate cyclase located on the inner side of the plasma membrane and anchored at various locations in the interior of the cell.[1] Adenylate cyclase is activated by a range of signaling molecules through the activation of adenylate cyclase stimulatory G (Gs)-protein-coupled receptors. Adenylate cyclase is inhibited by agonists of adenylate cyclase inhibitory G (Gi)-protein-coupled receptors. Liver adenylate cyclase responds more strongly to glucagon, and muscle adenylate cyclase responds more strongly to adrenaline. cAMP decomposition into AMP is catalyzed by the enzyme phosphodiesterase.

Check Digit Verification of cas no

The CAS Registry Mumber 60-92-4 includes 5 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 2 digits, 6 and 0 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 60-92:
(4*6)+(3*0)+(2*9)+(1*2)=44
44 % 10 = 4
So 60-92-4 is a valid CAS Registry Number.
InChI:InChI=1/C10H12N5O6P/c11-8-5-9(13-2-12-8)15(3-14-5)10-6(16)7-4(20-10)1-19-22(17,18)21-7/h2-4,6-7,10,16H,1H2,(H,17,18)(H2,11,12,13)/p-1/t4-,6-,7-,10-/m1/s1

60-92-4 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (A2381)  Adenosine 3',5'-Cyclic Monophosphate Hydrate  >99.0%(HPLC)

  • 60-92-4

  • 1g

  • 990.00CNY

  • Detail
  • TCI America

  • (A2381)  Adenosine 3',5'-Cyclic Monophosphate Hydrate  >99.0%(HPLC)

  • 60-92-4

  • 5g

  • 3,490.00CNY

  • Detail
  • Sigma

  • (A9501)  Adenosine3′,5′-cyclicmonophosphate  ≥98.5% (HPLC), powder

  • 60-92-4

  • A9501-1G

  • 2,439.45CNY

  • Detail
  • Sigma

  • (A9501)  Adenosine3′,5′-cyclicmonophosphate  ≥98.5% (HPLC), powder

  • 60-92-4

  • A9501-5G

  • 9,313.20CNY

  • Detail
  • Sigma

  • (A9501)  Adenosine3′,5′-cyclicmonophosphate  ≥98.5% (HPLC), powder

  • 60-92-4

  • A9501-25G

  • 28,629.90CNY

  • Detail

60-92-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 3',5'-cyclic AMP

1.2 Other means of identification

Product number -
Other names Adenosine cyclic 3‘,5‘-(hydrogen phosphate)

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:60-92-4 SDS

60-92-4Synthetic route

C22H38N6O6P(1+)

C22H38N6O6P(1+)

methyl iodide
74-88-4

methyl iodide

A

O3',O5'-methoxyphosphoryl-adenosine
58937-08-9, 62742-70-5, 62989-52-0

O3',O5'-methoxyphosphoryl-adenosine

B

O3',O5'-hydroxyphosphoryl-1-methyl-6,N6-didehydro-1,6-dihydro-adenosine
50884-82-7

O3',O5'-hydroxyphosphoryl-1-methyl-6,N6-didehydro-1,6-dihydro-adenosine

C

cAMP
60-92-4

cAMP

Conditions
ConditionsYield
With sodium carbonate In N,N-dimethyl acetamide at 80℃; for 0.0833333h; Yields of byproduct given;A 68.5%
B n/a
C n/a
benzyl bromide
100-39-0

benzyl bromide

C22H38N6O6P(1+)

C22H38N6O6P(1+)

A

(4aR,6R,7R,7aS)-6-(1-Benzyl-6-imino-1,6-dihydro-purin-9-yl)-2-oxo-tetrahydro-2λ5-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol
55053-32-2

(4aR,6R,7R,7aS)-6-(1-Benzyl-6-imino-1,6-dihydro-purin-9-yl)-2-oxo-tetrahydro-2λ5-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol

B

(4aR,6R,7R,7aS)-6-(1-Benzyl-6-imino-1,6-dihydro-purin-9-yl)-2-benzyloxy-2-oxo-tetrahydro-2λ5-furo[3,2-d][1,3,2]dioxaphosphinin-7-ol
137157-07-4

(4aR,6R,7R,7aS)-6-(1-Benzyl-6-imino-1,6-dihydro-purin-9-yl)-2-benzyloxy-2-oxo-tetrahydro-2λ5-furo[3,2-d][1,3,2]dioxaphosphinin-7-ol

C

cAMP
60-92-4

cAMP

D

cAMP benzyl ester
62742-71-6

cAMP benzyl ester

Conditions
ConditionsYield
With sodium carbonate In N,N-dimethyl acetamide at 80℃; for 0.25h;A n/a
B 0.7%
C n/a
D 34%
With sodium carbonate In N,N-dimethyl acetamide at 80℃; for 0.25h; Product distribution; other alkyl halide; var. inorganic carbonates;A 2 % Chromat.
B 5 % Chromat.
C 17 % Chromat.
D 74 % Chromat.
C10H12Cl2N5O5P
34051-17-7

C10H12Cl2N5O5P

cAMP
60-92-4

cAMP

Conditions
ConditionsYield
With potassium hydroxide In water; acetonitrile at 0℃; Yield given;
2-carboxy-1,N6-etheno adenosine 3',5'-cyclic phosphate
73706-11-3

2-carboxy-1,N6-etheno adenosine 3',5'-cyclic phosphate

cAMP
60-92-4

cAMP

Conditions
ConditionsYield
In dimethyl sulfoxide Heating; role of the 1,N6-etheno bridge in decarboxylation (without that decarboxylation did not take place at all);
desyl adenosine cyclic 3',5'-phosphate
143546-26-3

desyl adenosine cyclic 3',5'-phosphate

A

2-phenylbenzofuran
1839-72-1

2-phenylbenzofuran

B

cAMP
60-92-4

cAMP

Conditions
ConditionsYield
In 1,4-dioxane; water Quantum yield; Rate constant; Mechanism; Irradiation; var. solvents, var. pH;
With Tris buffer In water-d2 at 40℃; Quantum yield; Irradiation;
<4-(7-Methoxycoumarinyl)>methyl adenosine cyclic 3',5'-monophosphate

<4-(7-Methoxycoumarinyl)>methyl adenosine cyclic 3',5'-monophosphate

A

6-methoxy-1-hydroxymethyl-3-oxo-3H-benzopyran
72433-26-2

6-methoxy-1-hydroxymethyl-3-oxo-3H-benzopyran

B

cAMP
60-92-4

cAMP

Conditions
ConditionsYield
With water In 1,4-dioxane Irradiation;
equatorial-(7-methoxycoumarin-4-yl)methyl adenosine cyclic 3',5'-monophosphate

equatorial-(7-methoxycoumarin-4-yl)methyl adenosine cyclic 3',5'-monophosphate

A

6-methoxy-1-hydroxymethyl-3-oxo-3H-benzopyran
72433-26-2

6-methoxy-1-hydroxymethyl-3-oxo-3H-benzopyran

B

cAMP
60-92-4

cAMP

Conditions
ConditionsYield
With HEPES buffer In methanol; water Quantum yield; photolytic cleavage; UV-irradiation;
In methanol; water pH=7.2; Quantum yield; UV-irradiation;
axial-(7-methoxycoumarin-4-yl)methyl adenosine cyclic 3',5'-monophosphate

axial-(7-methoxycoumarin-4-yl)methyl adenosine cyclic 3',5'-monophosphate

A

6-methoxy-1-hydroxymethyl-3-oxo-3H-benzopyran
72433-26-2

6-methoxy-1-hydroxymethyl-3-oxo-3H-benzopyran

B

cAMP
60-92-4

cAMP

Conditions
ConditionsYield
With HEPES buffer In methanol; water Quantum yield; photolytic cleavage; UV-irradiation;
In methanol; water pH=7.2; Quantum yield; UV-irradiation;
adenosine 5'-diphosphate
58-64-0

adenosine 5'-diphosphate

adenylate-cyclase

adenylate-cyclase

cAMP
60-92-4

cAMP

AMP

AMP

cAMP
60-92-4

cAMP

Conditions
ConditionsYield
With pyridine; tributyl-amine; dicyclohexyl-carbodiimide
ATP( disodium-salt)

ATP( disodium-salt)

cAMP
60-92-4

cAMP

Conditions
ConditionsYield
With barium dihydroxide
adenylate-cyclase

adenylate-cyclase

A

cAMP
60-92-4

cAMP

B

pyrophosphate

pyrophosphate

equatorial-[7-(diethylamino)coumarin-4-yl]methyl adenosine cyclic 3',5'-monophosphate
339291-47-3

equatorial-[7-(diethylamino)coumarin-4-yl]methyl adenosine cyclic 3',5'-monophosphate

cAMP
60-92-4

cAMP

Conditions
ConditionsYield
In water Quantum yield; Irradiation;
axial-[7-(diethylamino)coumarin-4-yl]methyl adenosine cyclic 3',5'-monophosphate
339291-37-1

axial-[7-(diethylamino)coumarin-4-yl]methyl adenosine cyclic 3',5'-monophosphate

cAMP
60-92-4

cAMP

Conditions
ConditionsYield
In water Quantum yield; Irradiation;
[7-(carboxymethoxy)coumarin-4-yl]methyl ester of cAMP
339291-49-5

[7-(carboxymethoxy)coumarin-4-yl]methyl ester of cAMP

cAMP
60-92-4

cAMP

Conditions
ConditionsYield
In water Quantum yield; Irradiation;
[7-(carboxymethoxy)coumarin-4-yl]methyl ester of cAMP
339291-40-6

[7-(carboxymethoxy)coumarin-4-yl]methyl ester of cAMP

cAMP
60-92-4

cAMP

Conditions
ConditionsYield
In water Quantum yield; Irradiation;
cyclic adenosine-3',5'-monophosphate [6,7-bis(carboxymethoxy)coumarin-4-yl]methyl ester
339291-51-9

cyclic adenosine-3',5'-monophosphate [6,7-bis(carboxymethoxy)coumarin-4-yl]methyl ester

cAMP
60-92-4

cAMP

Conditions
ConditionsYield
In water Quantum yield; Irradiation;
cyclic adenosine-3',5'-monophosphate [6,7-bis(carboxymethoxy)coumarin-4-yl]methyl ester
339291-41-7

cyclic adenosine-3',5'-monophosphate [6,7-bis(carboxymethoxy)coumarin-4-yl]methyl ester

cAMP
60-92-4

cAMP

Conditions
ConditionsYield
In water Quantum yield; Irradiation;
equatorial-[7-(diethylamino)coumarin-4-yl]methyl adenosine cyclic 3',5'-monophosphate
339291-47-3

equatorial-[7-(diethylamino)coumarin-4-yl]methyl adenosine cyclic 3',5'-monophosphate

A

7-(diethylamino)-4-(hydroxymethyl)-2H-chromen-2-one
54711-38-5

7-(diethylamino)-4-(hydroxymethyl)-2H-chromen-2-one

B

cAMP
60-92-4

cAMP

Conditions
ConditionsYield
In methanol; water pH=7.2; Quantum yield; UV-irradiation;
axial-[7-(diethylamino)coumarin-4-yl]methyl adenosine cyclic 3',5'-monophosphate
339291-37-1

axial-[7-(diethylamino)coumarin-4-yl]methyl adenosine cyclic 3',5'-monophosphate

A

7-(diethylamino)-4-(hydroxymethyl)-2H-chromen-2-one
54711-38-5

7-(diethylamino)-4-(hydroxymethyl)-2H-chromen-2-one

B

cAMP
60-92-4

cAMP

Conditions
ConditionsYield
In methanol; water pH=7.2; Quantum yield; UV-irradiation;
equatorial-(coumarin-4-yl)methyl adenosine cyclic 3',5'-monophosphate
402755-29-7

equatorial-(coumarin-4-yl)methyl adenosine cyclic 3',5'-monophosphate

A

4-(hydroxymethyl)coumarin
35893-97-1

4-(hydroxymethyl)coumarin

B

cAMP
60-92-4

cAMP

Conditions
ConditionsYield
In methanol; water pH=7.2; Quantum yield; UV-irradiation;
axial-(coumarin-4-yl)methyl adenosine cyclic 3',5'-monophosphate
402755-28-6

axial-(coumarin-4-yl)methyl adenosine cyclic 3',5'-monophosphate

A

4-(hydroxymethyl)coumarin
35893-97-1

4-(hydroxymethyl)coumarin

B

cAMP
60-92-4

cAMP

Conditions
ConditionsYield
In methanol; water pH=7.2; Quantum yield; UV-irradiation;
equatorial-(6-methoxycoumarin-4-yl)methyl adenosine cyclic 3',5'-monophosphate
402755-32-2

equatorial-(6-methoxycoumarin-4-yl)methyl adenosine cyclic 3',5'-monophosphate

A

cAMP
60-92-4

cAMP

B

4-(hydroxymethyl)-6-methoxycoumarin

4-(hydroxymethyl)-6-methoxycoumarin

Conditions
ConditionsYield
In methanol; water pH=7.2; Quantum yield; UV-irradiation;
axial-(6-methoxycoumarin-4-yl)methyl adenosine cyclic 3',5'-monophosphate
402755-30-0

axial-(6-methoxycoumarin-4-yl)methyl adenosine cyclic 3',5'-monophosphate

A

cAMP
60-92-4

cAMP

B

4-(hydroxymethyl)-6-methoxycoumarin

4-(hydroxymethyl)-6-methoxycoumarin

Conditions
ConditionsYield
In methanol; water pH=7.2; Quantum yield; UV-irradiation;
equatorial-[7-(dimethylamino)coumarin-4-yl]methyl adenosine cyclic 3',5'-monophosphate

equatorial-[7-(dimethylamino)coumarin-4-yl]methyl adenosine cyclic 3',5'-monophosphate

A

cAMP
60-92-4

cAMP

B

7-(dimethylamino)-4-(hydroxymethyl)-2H-chromen-2-one
105567-75-7

7-(dimethylamino)-4-(hydroxymethyl)-2H-chromen-2-one

Conditions
ConditionsYield
In methanol; water pH=7.2; Quantum yield; UV-irradiation;
axial-[7-(dimethylamino)coumarin-4-yl]methyl adenosine cyclic 3',5'-monophosphate

axial-[7-(dimethylamino)coumarin-4-yl]methyl adenosine cyclic 3',5'-monophosphate

A

cAMP
60-92-4

cAMP

B

7-(dimethylamino)-4-(hydroxymethyl)-2H-chromen-2-one
105567-75-7

7-(dimethylamino)-4-(hydroxymethyl)-2H-chromen-2-one

Conditions
ConditionsYield
In methanol; water pH=7.2; Quantum yield; UV-irradiation;
equatorial-(6,7-dimethoxycoumarin-4-yl)methyl adenosine cyclic 3',5'-monophosphate

equatorial-(6,7-dimethoxycoumarin-4-yl)methyl adenosine cyclic 3',5'-monophosphate

A

cAMP
60-92-4

cAMP

B

6,7-dimethoxy-4-(hydroxymethyl)coumarin
402755-39-9

6,7-dimethoxy-4-(hydroxymethyl)coumarin

Conditions
ConditionsYield
In methanol; water pH=7.2; Quantum yield; UV-irradiation;
axial-(6,7-dimethoxycoumarin-4-yl)methyl adenosine cyclic 3',5'-monophosphate
402755-34-4

axial-(6,7-dimethoxycoumarin-4-yl)methyl adenosine cyclic 3',5'-monophosphate

A

cAMP
60-92-4

cAMP

B

6,7-dimethoxy-4-(hydroxymethyl)coumarin
402755-39-9

6,7-dimethoxy-4-(hydroxymethyl)coumarin

Conditions
ConditionsYield
In methanol; water pH=7.2; Quantum yield; UV-irradiation;
Diadenosine triphosphate
5959-90-0

Diadenosine triphosphate

A

cAMP
60-92-4

cAMP

B

5'-adenosine monophosphate
61-19-8

5'-adenosine monophosphate

C

adenosine 5'-diphosphate
58-64-0

adenosine 5'-diphosphate

D

C20H29N10O17P3

C20H29N10O17P3

Conditions
ConditionsYield
With sodium hydroxide at 90℃; Kinetics; Product distribution; Further Variations:; pH-values;
cAMP
60-92-4

cAMP

calcium dibutyryl cyclic adenosine monophosphate

calcium dibutyryl cyclic adenosine monophosphate

Conditions
ConditionsYield
With calcium chloride In ethanol; water at 20℃; for 0.166667h;96.98%
butanoic acid anhydride
106-31-0

butanoic acid anhydride

cAMP
60-92-4

cAMP

dibutyryl cyclic AMP
362-74-3

dibutyryl cyclic AMP

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 80℃; for 7h; Solvent; Reagent/catalyst; Temperature; Inert atmosphere;96.09%
cAMP
60-92-4

cAMP

adenosine 3',5'-(cyclic)phosphate monosodium salt
37839-81-9

adenosine 3',5'-(cyclic)phosphate monosodium salt

Conditions
ConditionsYield
With sodium hydroxide In water at 40℃; for 0.666667h; pH=6.6 - 6.7; Temperature;96%
cAMP
60-92-4

cAMP

C10H11N5O6P(1-)*0.5Ca(2+)

C10H11N5O6P(1-)*0.5Ca(2+)

Conditions
ConditionsYield
With calcium carbonate In water at 60℃; for 0.833333h; pH=6.7 - 6.8; Reagent/catalyst; Temperature;93.8%
cAMP
60-92-4

cAMP

inosine 3′,5′-cyclic monophosphate
3545-76-4

inosine 3′,5′-cyclic monophosphate

Conditions
ConditionsYield
With phosphate buffer at 25℃; for 5h; AMP deaminase from Aspergillus sp.;93%
cAMP
60-92-4

cAMP

p-toluenesulfonyl chloride
98-59-9

p-toluenesulfonyl chloride

2'-O-Tosyl cAMP
77056-11-2

2'-O-Tosyl cAMP

Conditions
ConditionsYield
With sodium hydroxide In 1,4-dioxane Ambient temperature;80%
cAMP
60-92-4

cAMP

Br-cAMP
23583-48-4

Br-cAMP

Conditions
ConditionsYield
With bromine; sodium acetate In water at 20℃; for 24h;76%
With bromine; sodium acetate In water at 20℃; for 25h;76%
With bromine; sodium acetate In water at 20℃; for 24h;
(E)-di-tert-butyl 2-(3-(7-(diethylamino)-4-(((methylsulfonyl)oxy)methyl)-2-oxo-2H-chromen-3-yl)acrylamido)succinate

(E)-di-tert-butyl 2-(3-(7-(diethylamino)-4-(((methylsulfonyl)oxy)methyl)-2-oxo-2H-chromen-3-yl)acrylamido)succinate

cAMP
60-92-4

cAMP

C39H50N7O13P

C39H50N7O13P

Conditions
ConditionsYield
Stage #1: cAMP With tributyl-amine In methanol; ethanol for 1h; Reflux;
Stage #2: (E)-di-tert-butyl 2-(3-(7-(diethylamino)-4-(((methylsulfonyl)oxy)methyl)-2-oxo-2H-chromen-3-yl)acrylamido)succinate In acetonitrile for 2.5h; Reflux;
65%
[Ru2Cl2(N,N′‑diphenylformamidinate)3]

[Ru2Cl2(N,N′‑diphenylformamidinate)3]

cAMP
60-92-4

cAMP

[Ru2Cl(N,N′‑diphenylformamidinate)3(deprotonated adenosine-3′,5′-cyclic monophosphate)]

[Ru2Cl(N,N′‑diphenylformamidinate)3(deprotonated adenosine-3′,5′-cyclic monophosphate)]

Conditions
ConditionsYield
In methanol at 20℃; for 25.5h;57%
benzyl bromide
100-39-0

benzyl bromide

cAMP
60-92-4

cAMP

cAMP benzyl ester
62742-71-6

cAMP benzyl ester

Conditions
ConditionsYield
With silver(l) oxide In dimethyl sulfoxide; acetonitrile at 65℃; for 18h;52%
4-(bromomethyl)-7-methoxycoumarin
35231-44-8

4-(bromomethyl)-7-methoxycoumarin

cAMP
60-92-4

cAMP

<4-(7-Methoxycoumarinyl)>methyl adenosine cyclic 3',5'-monophosphate

<4-(7-Methoxycoumarinyl)>methyl adenosine cyclic 3',5'-monophosphate

Conditions
ConditionsYield
With silver(l) oxide In dimethyl sulfoxide; acetonitrile at 60℃; for 45h;44%
(2E)-cyclooct-2’-en-1’-yl 4-nitrophenyl carbonate

(2E)-cyclooct-2’-en-1’-yl 4-nitrophenyl carbonate

cAMP
60-92-4

cAMP

C19H24N5O8P

C19H24N5O8P

Conditions
ConditionsYield
With dmap In N,N-dimethyl-formamide at 30℃; for 18h;38%
cAMP
60-92-4

cAMP

2-bromomethylnaphthyl bromide
939-26-4

2-bromomethylnaphthyl bromide

A

equatorial-2-Naphthylmethyl adenosine cyclic 3',5'-monophosphate

equatorial-2-Naphthylmethyl adenosine cyclic 3',5'-monophosphate

B

axial-2-Naphthylmethyl adenosine cyclic 3',5'-monophosphate

axial-2-Naphthylmethyl adenosine cyclic 3',5'-monophosphate

Conditions
ConditionsYield
With silver(l) oxide In dimethyl sulfoxide; acetonitrile at 60℃; for 45h;A 31%
B 27%
2-(bromomethyl)anthraquinone
7598-10-9

2-(bromomethyl)anthraquinone

cAMP
60-92-4

cAMP

(2-Anthraquinonyl)methyl adenosine cyclic 3',5'-monophosphate

(2-Anthraquinonyl)methyl adenosine cyclic 3',5'-monophosphate

Conditions
ConditionsYield
With silver(l) oxide In dimethyl sulfoxide; acetonitrile at 60℃; for 45h;14%
1-methyl-4-nitrosobenzene
623-11-0

1-methyl-4-nitrosobenzene

cAMP
60-92-4

cAMP

7H-purin-6-ylamine
73-24-5

7H-purin-6-ylamine

Conditions
ConditionsYield
at 98℃; zeitlicher Verlauf.Hydrolysis;
at 100℃; zeitlicher Verlauf.Hydrolysis;
cAMP
60-92-4

cAMP

phosphoric acid inosine-3',5'-diyl ester
3545-76-4, 54621-38-4

phosphoric acid inosine-3',5'-diyl ester

Conditions
ConditionsYield
With potassium nitrite; water wss.Loesung vom pH 3;
cAMP
60-92-4

cAMP

A

adenosine monophosphate
84-21-9

adenosine monophosphate

B

5'-adenosine monophosphate
61-19-8

5'-adenosine monophosphate

Conditions
ConditionsYield
With cerium(III) chloride; water at 30℃; Rate constant; Mechanism; pH 8.0; velocity const. - var. pH's dependence;
With buffer pH 7; tris(3-aminopropyl)amine cobalt(III) hydroxo aqua at 25℃; relative rates of hydrolysis to the monoesters 3'-AMP and 5'-AMP; var. cobalt(III)-complexes;
With hydrogenchloride at 90.1℃; Rate constant;
furfural
98-01-1

furfural

cAMP
60-92-4

cAMP

(4aR,6R,7R,7aS)-6-(6-{[1-Furan-2-yl-meth-(Z)-ylidene]-amino}-purin-9-yl)-2-oxo-tetrahydro-2λ5-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol

(4aR,6R,7R,7aS)-6-(6-{[1-Furan-2-yl-meth-(Z)-ylidene]-amino}-purin-9-yl)-2-oxo-tetrahydro-2λ5-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol

Conditions
ConditionsYield
With tributyl-amine In acetic acid at 50℃; for 0.5h;
Iodoethanol
624-76-0

Iodoethanol

cAMP
60-92-4

cAMP

6-Amino-9-((4aR,6R,7R,7aS)-2,7-dihydroxy-2-oxo-tetrahydro-2λ5-furo[3,2-d][1,3,2]dioxaphosphinin-6-yl)-1-(2-hydroxy-ethyl)-9H-purin-1-ium

6-Amino-9-((4aR,6R,7R,7aS)-2,7-dihydroxy-2-oxo-tetrahydro-2λ5-furo[3,2-d][1,3,2]dioxaphosphinin-6-yl)-1-(2-hydroxy-ethyl)-9H-purin-1-ium

Conditions
ConditionsYield
With sodium hydroxide; silver nitrate 1.) water; 2.) DMF, rt, 3 days; Yield given. Multistep reaction;
butanoic acid anhydride
106-31-0

butanoic acid anhydride

cAMP
60-92-4

cAMP

sodium bucladesine

sodium bucladesine

Conditions
ConditionsYield
With barium(II) iodide; sodium perchlorate; triethylamine 1.) pyridine, heating 3-4 min, then Rt, 6 d; 2.) water, methanol, ether; 3.) methanol, acetone; Multistep reaction;
nonan-1-al
124-19-6

nonan-1-al

cAMP
60-92-4

cAMP

(4aR,6R,7R,7aS)-6-[6-Non-(Z)-ylideneamino-purin-9-yl]-2-oxo-tetrahydro-2λ5-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol

(4aR,6R,7R,7aS)-6-[6-Non-(Z)-ylideneamino-purin-9-yl]-2-oxo-tetrahydro-2λ5-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol

Conditions
ConditionsYield
With tributyl-amine In acetic acid at 50℃; for 0.5h;
cAMP
60-92-4

cAMP

(4aR,6R,7R,7aS)-6-[1-((E)-But-2-enyl)-6-imino-1,6-dihydro-purin-9-yl]-2-oxo-tetrahydro-2λ5-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol

(4aR,6R,7R,7aS)-6-[1-((E)-But-2-enyl)-6-imino-1,6-dihydro-purin-9-yl]-2-oxo-tetrahydro-2λ5-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol

Conditions
ConditionsYield
With 2,6-dimethylpyridine; 1,5-Diazabicyclo[5.4.0]undec-5-ene In N,N-dimethyl-formamide at 60℃; for 5h;146 g
caprinaldehyde
112-31-2

caprinaldehyde

cAMP
60-92-4

cAMP

(4aR,6R,7R,7aS)-6-[6-Dec-(Z)-ylideneamino-purin-9-yl]-2-oxo-tetrahydro-2λ5-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol

(4aR,6R,7R,7aS)-6-[6-Dec-(Z)-ylideneamino-purin-9-yl]-2-oxo-tetrahydro-2λ5-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol

Conditions
ConditionsYield
With tributyl-amine In acetic acid at 50℃; for 0.5h;
heptanal
111-71-7

heptanal

cAMP
60-92-4

cAMP

(4aR,6R,7R,7aS)-6-[6-Hept-(Z)-ylideneamino-purin-9-yl]-2-oxo-tetrahydro-2λ5-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol

(4aR,6R,7R,7aS)-6-[6-Hept-(Z)-ylideneamino-purin-9-yl]-2-oxo-tetrahydro-2λ5-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol

Conditions
ConditionsYield
With tributyl-amine In acetic acid at 50℃; for 0.5h;
pentanal
110-62-3

pentanal

cAMP
60-92-4

cAMP

(4aR,6R,7R,7aS)-2-Oxo-6-[6-pent-(Z)-ylideneamino-purin-9-yl]-tetrahydro-2λ5-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol

(4aR,6R,7R,7aS)-2-Oxo-6-[6-pent-(Z)-ylideneamino-purin-9-yl]-tetrahydro-2λ5-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol

Conditions
ConditionsYield
With tributyl-amine In acetic acid at 50℃; for 0.5h;
Octanal
124-13-0

Octanal

cAMP
60-92-4

cAMP

(4aR,6R,7R,7aS)-6-[6-Oct-(Z)-ylideneamino-purin-9-yl]-2-oxo-tetrahydro-2λ5-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol

(4aR,6R,7R,7aS)-6-[6-Oct-(Z)-ylideneamino-purin-9-yl]-2-oxo-tetrahydro-2λ5-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol

Conditions
ConditionsYield
With tributyl-amine In acetic acid at 50℃; for 0.5h;
myristylaldehyde
124-25-4

myristylaldehyde

cAMP
60-92-4

cAMP

(4aR,6R,7R,7aS)-2-Oxo-6-[6-tetradec-(Z)-ylideneamino-purin-9-yl]-tetrahydro-2λ5-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol

(4aR,6R,7R,7aS)-2-Oxo-6-[6-tetradec-(Z)-ylideneamino-purin-9-yl]-tetrahydro-2λ5-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol

Conditions
ConditionsYield
With tributyl-amine In chloroform; acetic acid at 50℃; for 0.5h;

60-92-4Relevant articles and documents

Structure and monomer/dimer equilibrium for the guanylyl cyclase domain of the optogenetics protein RhoGC

Kumar, Ramasamy P.,Morehouse, Benjamin R.,Fofana, Josiane,Trieu, Melissa M.,Zhou, Daniel H.,Lorenz, Molly O.,Oprian, Daniel D.

, p. 21578 - 21589 (2017)

RhoGC is a fusion protein from the aquatic fungus Blastocladiella emersonii, combining a type I rhodopsin domain with a guanylyl cyclase domain. It has generated excitement as an optogenetics tool for the manipulation of cyclic nucleotide signaling pathways. To investigate the regulation of the cyclase activity, we isolated the guanylyl cyclase domain from Escherichia coli with (GCwCCRho) and without (GCRho) the coiledcoil linker. Both constructs were constitutively active but were monomeric as determined by size-exclusion chromatography and analytical ultracentrifugation, whereas other class III nucleotidyl cyclases are functional dimers. We also observed that crystals of GCRho have only a monomer in an asymmetric unit. Dimers formed when crystals were grown in the presence of the non-cyclizable substrate analog 2′,3′-dideoxyguanosine- 5′-triphosphate, MnCl2, and tartrate, but their quaternary structure did not conform to the canonical pairing expected for class III enzymes. Moreover, the structure contained a disulfide bond formed with an active-site Cys residue required for activity. We consider it unlikely that the disulfide would form under intracellular reducing conditions, raising the possibility that this unusual dimer might have a biologically relevant role in the regulation of full-length RhoGC. Although we did not observe it with direct methods, a functional dimer was identified as the active state by following the dependence of activity on total enzymeconcentration. The low affinity observed for GCRhomonomers is unusual for this enzyme class and suggests that dimer formation may contribute to light activation of the full-length protein.

Photochemical Properties of New Photolabile cAMP Derivatives in a Physiological Saline Solution

Furuta, Toshiaki,Torigai, Hiromi,Sugimoto, Masazumi,Iwamura, Michiko

, p. 3953 - 3956 (1995)

Three new photolabile esters of cAMP (2-anthraquinonyl)methyl (1a), (7-methoxycoumarinyl)methyl (2a), and 2-naphthylmethyl (3a), have been developed.The stability and photochemical properties of these derivatives were compared to the previously reported ones in a physiological saline solution (1percent DMSO in Ringer's solution, pH 7.4).We found that 2a had satisfactory stability (t1/2 > 1000 h) in the dark and was photolyzed to release the parent cAMP on 340 nm irradiation (Φapp = 0.10, Ε340 = 6730) more efficiently than previously reported caged cAMPs.A biological test using the melanophores of the medaka (Oryzias latipes) revealed that 2a penetrated into the melanophores, inactive before irradiation and activated to release cAMP upon irradiation.We have developed a new caged cAMP which can be used in the investigation of biological responses regulated by intracellular cAMP concentrations using living cells.

ADENOSINE ANALOG AND ITS USE IN REGULATING THE CIRCADIAN CLOCK

-

Paragraph 0166; 0171; 0172; 0208, (2018/08/12)

Provided are a kind of nucleoside analogue compounds, and compositions comprising these compounds and pentostatin, their use for modulating circadian rhythm, preferably, for shifting circadian phase, and methods for modulating circadian rhythm, preferably, for shifting circadian phase via these compounds or the compositions.

Factors influencing the operational stability of NADPH-dependent alcohol dehydrogenase and an NADH-dependent variant thereof in gas/solid reactors

Kulishova, Liliya,Dimoula, Kerasina,Jordan, Max,Wirtz, Astrid,Hofmann, Diana,Santiago-Schuebel, Beatrix,Fitter, Joerg,Pohl, Martina,Spiess, Antje C.

experimental part, p. 271 - 283 (2011/02/22)

The continuous enzymatic gas/solid bio-reactor serves both for the production of volatile fine chemicals and flavors on an industrial scale and for thermodynamically controlled investigation of substrate and water effects on enzyme preparations for research purposes. Here, we comparatively investigated the molecular effects on the operational stability of NADPH-dependent Lactobacillus brevis alcohol dehydrogenase and an NADH-dependent variant thereof, LbADH G37D, in the gas/solid bioreactor. The reference reaction is the reduction of acetophenone to (R)-1-phenylethanol with concomitant oxidation of 2-propanol to acetone for the purpose of regeneration of the redox cofactor. It could be clearly shown that not the thermostability of the cofactor, but the thermostability of the proteins in the solid dry state govern the order of magnitude of the operational stability of both purified enzymes in the gas/solid reactor at low thermodynamic activity of water and substrate. However, at higher thermodynamic activity the operational stability in the gas/solid reactor is overlaid by stabilizing and destabilizing effects of the substrates that require further investigation. We demonstrated first evidence that the substrate affinity of the two variants in the gas/solid reactor is similar to the affinity in aqueous medium. We could also show that partial unfolding of the proteins with subsequent aggregation are the factors governing protein thermo-in-stability both in the dissolved and in the dry state. Thus, stability investigations of enzymes in the dry state are suggested to predict their basal level of operational stability in gas/solid reactions.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 60-92-4